Aplastic Anemia

156 clinical trials · Condition

Record	Firm	Date
Fludarabine Based Conditioning for Allogeneic Transplantation for Advanced Hematologic Malignancies (NCT01499147)	University of Illinois at Chicago	2000-02-01
A Study to Determine Whether Therapy With Daclizumab Will Benefit Patients With Bone Marrow Failure (NCT00001962)	National Heart, Lung, and Blood Institute (NHLBI)	1999-11-01
Nonmyeloablative Allo SCT for the Treatment of Hematologic Disorders (NCT00636909)	Beth Israel Deaconess Medical Center	1999-07-01
Phase III Randomized Study of Cyclophosphamide With or Without Antithymocyte Globulin Before Bone Marrow Transplantation in Patients With Aplastic Anemia (NCT00004474)	Roswell Park Cancer Institute	1998-09-01
Protection Against Benzene Toxicity (NCT00011453)	National Institute of Environmental Health Sciences (NIEHS)	1998-07-01
Blood Transplantation for Patients With Hematologic Malignancies or Bone Marrow Failure States (NCT00038779)	M.D. Anderson Cancer Center	1996-08-14
Study of High Dose Cyclophosphamide in Patients With Severe Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria (NCT00004464)	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	1996-02-01
Phase II Study of Bone Marrow Transplantation Using Related Donors in Patients With Aplastic Anemia (NCT00004323)	National Center for Research Resources (NCRR)	1995-02-01
Stem Cell Factor Medication for Aplastic Anemia (NCT00001398)	National Heart, Lung, and Blood Institute (NHLBI)	1993-10-01
Expanded Access Use of Itacitinib to Treat a Single Patient With Aplastic Anemia (NCT03906318)	Incyte Corporation

Track Aplastic Anemia automatically

Every clearance here is in the API, with alerts when new ones post.